[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100571979":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":56,"collaborators":58,"id":63,"slug":25,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":69,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":25,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":84,"overallStatus":38,"whyStopped":25,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Finzelberg GmbH & Co. KG","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Placebo","PLACEBO_COMPARATOR","The placebo has similar characteristics as the verum instant drink.",[13],"Dietary Supplement: Placebo",{"label":15,"type":16,"description":17,"interventionNames":18},"Food supplement","EXPERIMENTAL","Powder for an instant drink preparation with orange flavor \u002Ftaste",[19],"Dietary Supplement: Food supplement",[21,26],{"type":22,"name":15,"description":23,"armGroupLabels":24,"otherNames":25},"DIETARY_SUPPLEMENT","Instant drink in a powder form presented in a sachet to be disolved in a glass of water (200 ml).",[15],null,{"type":22,"name":9,"description":27,"armGroupLabels":28,"otherNames":25},"Instant drink in powder form in a sachet to be disolved in a glass of water (200ml)",[9],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Cynthia G Suarez, PhD","CONTACT","004916098144462","cynthia.suarez-rizzo@finzelberg.com",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Eurofins Dermscan Poland","RECRUITING","Gdansk","GDANSK","288","Poland",{"type":44,"coordinates":45},"Point",[46,47],18.64912,54.35227,{"lat":47,"lon":46},[50,54],{"name":51,"role":32,"phone":52,"phoneExt":25,"email":53},"Maja Kreyzmon, Project manager","0058 7320290","Maja.Jaskolska@cpt.eurofinseu.com",{"name":55,"role":32,"phone":25,"phoneExt":25,"email":25},"Maja KREZYMON",{"type":57,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[59,61],{"name":60,"class":6},"Eurofins",{"name":62,"class":6},"Eurofins Dermscan Pharmascan","100571979",false,"NCT06727292","Biometrical Evaluation of the Efficacy of a Food Supplement Versus Placebo","FB_BfW","Inclusion Criteria:\n\n* Phototype: I to IV;\n* Subjects with normal to dry skin;\n* Subjects with healthy skin on the study area;\n* Non-smokers;\n* Has normal nutritional habits (not vegetarian\u002Fvegan);\n* Is not pregnant or lactating;\n* Has a BMI of 18 - 33 kg\u002Fm2;\n* Is willing to refrain from taking dietary supplements (at best not at all, in any case not during the last month before study start);\n* Willing not to use any oral products or any nutritional supplementation aiming at improving skin status during the course of the study;\n* No history of malabsorption diseases, liver diseases, or diseases of the lipid metabolism;\n* Uses no medication, which may interact with the study product\n\nExclusion Criteria:\n\n* For women: pregnant or nursing woman or woman planning to get pregnant during the study;\n* Cutaneous pathology on the study zone (eczema, etc.);\n* Subject with make-up on the day of the visit at the laboratory;\n* Use of topical or systemic treatment during the previous weeks liable to interfere with the assessment of the efficacy of the study product:\n\n  * change in anti-wrinkle, smoothing and\u002For firming topical products within previous week on the studied zones,\n  * non-invasive procedures within previous month on the studied zones,\n  * intake of food supplement acting on skin within the three previous months,\n  * invasive procedures:\n\n    * deep chemical peeling within previous 3 months on the studied zones,\n    * mesotherapy, dermapen, laser within previous 6 months on the studied zones,\n    * botox and\u002For hyaluronic acid injections within previous 12 months on the studied zones;\n* Intake of vitamin substances and diets comprising a change of normal eating habits;\n* Known allergy to one or several investigational product´s ingredients;\n* Participation in a nutritional study within the last 30 days;\n* Surgical or internal diseases e.g. a metabolic or endocrine disease that may affect the outcome of the study (e.g. diabetes, liver diseases, kidney disorders) or having a history of medical or surgical events that may significantly affect the study outcome including any cardiovascular disease, skin disease, hypertension (\\>140\u002F90 mm Hg in three repeated measurements).",true,"FEMALE","45 Years","65 Years",{"count":74,"type":75},66,"ESTIMATED","INTERVENTIONAL",[78],"NA","The purpose of this clinical trial is to evaluate whether nutritional supplementation over a 2-month period improves skin physiological parameters. This is a national, single-center, double-blind, randomized pilot study.\n\nThe study will be conducted using a supplement and a placebo, the safety of which has been assured by the sponsor.\n\nParticipants will:\n\n* Take a food supplement or a placebo once daily for 2 months\n* Visit the study center at beginning, after 28 days and after 56 days of supplementation.\n* Keep a diary of their skin status and tolerability\n\nThe secondary objective is to evaluate product characteristics and performance during normal use in healthy subjects.",[81,82,83],"Skin Aging","Hair Condition","Skin Condition",[85],"improvements of skin physiological parameters","2024-12-06",{"date":88,"type":89},"2024-12-10","ACTUAL",{"date":91,"type":89},"2024-10-14",{"date":93,"type":75},"2025-05-30",{"name":5,"class":6},1]